• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较澳大利亚、法国和拉丁美洲 2 型糖尿病患者的临床代谢监测及结果和冠心病风险状况。

Comparison of clinical-metabolic monitoring and outcomes and coronary risk status in people with type 2 diabetes from Australia, France and Latin America.

机构信息

Center of Experimental and Applied Endocrinology (CENEXA, National University of La Plata-National Research Council of La Plata), PAHO/WHO Collaborating Center for Diabetes Research, Education, and Care, La Plata, Argentina.

出版信息

Diabetes Res Clin Pract. 2010 Apr;88(1):7-13. doi: 10.1016/j.diabres.2009.12.024. Epub 2010 Feb 12.

DOI:10.1016/j.diabres.2009.12.024
PMID:20153542
Abstract

AIM

To compare clinical-metabolic monitoring and coronary risk status in people with type 2 diabetes from Australia, France and Latin America.

METHODS

Retrospective analysis of data collected at primary care (except ANDIAB--secondary care) [corrected] matched for age, gender and disease duration. Measurements included participants' characteristics, performance frequency of clinical-metabolic process indicators, and percentage of clinical-metabolic outcomes at recommended target values.

RESULTS

The weighted mean of the percentage of process performance was within 68 to 81%; that of outcomes at target dropped to 29 to 45%. Although statistically significant, differences among groups were far from those in healthcare budgets, and probably only of marginal clinical impact. The percentage of patients with low, slight or high coronary risk was similar in the three groups, with most people at high or very high risk.

CONCLUSIONS

Despite the high difference in health per capita investment and system characteristics among countries, the study populations had striking similarities regarding the low percentage of participants who achieved cardiovascular risk factor and diabetes treatment goals. Therefore, differences in health budget and system characteristics would not be the main drivers in care quality. Diabetes education at every level and quality care registries would contribute to improve this situation and assess such improvement.

摘要

目的

比较来自澳大利亚、法国和拉丁美洲的 2 型糖尿病患者的临床代谢监测和冠状动脉风险状况。

方法

对初级保健(ANDIAB 除外-二级保健)[更正]收集的数据进行回顾性分析,按年龄、性别和疾病持续时间进行匹配。测量包括参与者的特征、临床代谢过程指标的执行频率以及临床代谢结果达到推荐目标值的百分比。

结果

过程表现的加权平均值在 68%至 81%之间;达到目标的结果则下降到 29%至 45%。尽管存在统计学上的显著差异,但各群组之间的差异远不及医疗保健预算之间的差异,可能仅具有边际临床意义。三组中低、轻度或高冠状动脉风险的患者百分比相似,大多数人处于高或极高风险。

结论

尽管各国的人均卫生投入和系统特征存在很大差异,但研究人群在心血管风险因素和糖尿病治疗目标方面达到的参与者百分比却惊人地相似。因此,卫生预算和系统特征的差异并不是护理质量的主要驱动因素。在各个层面进行糖尿病教育和质量护理登记将有助于改善这种情况,并评估这种改善。

相似文献

1
Comparison of clinical-metabolic monitoring and outcomes and coronary risk status in people with type 2 diabetes from Australia, France and Latin America.比较澳大利亚、法国和拉丁美洲 2 型糖尿病患者的临床代谢监测及结果和冠心病风险状况。
Diabetes Res Clin Pract. 2010 Apr;88(1):7-13. doi: 10.1016/j.diabres.2009.12.024. Epub 2010 Feb 12.
2
Patients' education, and its impact on care outcomes, resource consumption and working conditions: data from the International Diabetes Management Practices Study (IDMPS).患者教育及其对护理结局、资源消耗和工作条件的影响:来自国际糖尿病管理实践研究 (IDMPS)的数据。
Diabetes Metab. 2012 Apr;38(2):128-34. doi: 10.1016/j.diabet.2011.09.002. Epub 2011 Oct 22.
3
[Efficiency versus quality in the NHS, in Portugal: methodologies for evaluation].葡萄牙国民医疗服务体系中的效率与质量:评估方法
Acta Med Port. 2008 Sep-Oct;21(5):397-410. Epub 2009 Jan 16.
4
Quality of care for patients with type 2 diabetes mellitus in the Netherlands and the United States: a comparison of two quality improvement programs.荷兰和美国2型糖尿病患者的护理质量:两项质量改进计划的比较。
Health Serv Res. 2004 Aug;39(4 Pt 1):709-25. doi: 10.1111/j.1475-6773.2004.00254.x.
5
Acute coronary syndromes in indigenous Australians: opportunities for improving outcomes across the continuum of care.澳大利亚原住民的急性冠状动脉综合征:改善整个连续护理过程中结局的机会。
Heart Lung Circ. 2010 May-Jun;19(5-6):325-36. doi: 10.1016/j.hlc.2010.02.011. Epub 2010 Apr 2.
6
[Management of severe hypertension in France in 1999 and 2000: intermediate results of a health insurance intervention program].[1999年和2000年法国重度高血压的管理:一项医疗保险干预计划的中期结果]
Arch Mal Coeur Vaiss. 2002 Jul-Aug;95(7-8):687-94.
7
French medical practice in type 2 diabetes: the need for better control of cardiovascular risk factors.法国2型糖尿病的医疗实践:更好控制心血管危险因素的必要性。
Diabetes Metab. 2008 Feb;34(1):38-45. doi: 10.1016/j.diabet.2007.09.003.
8
Secondary prevention for acute coronary syndrome in rural South Australia: are drugs best? What about the rest?南澳大利亚农村地区急性冠状动脉综合征的二级预防:药物是最佳选择吗?其他方面呢?
Rural Remote Health. 2008 Oct-Dec;8(4):967. Epub 2008 Oct 14.
9
Cholesterol complacency in Australia: time to revisit the basics of cardiovascular disease prevention.澳大利亚的胆固醇自满情绪:是时候重新审视心血管疾病预防的基础知识了。
J Clin Nurs. 2009 Mar;18(5):678-86. doi: 10.1111/j.1365-2702.2008.02507.x. Epub 2008 Nov 25.
10
High prevalence of diabetes and impaired fasting glucose in urban Latin America: the CARMELA Study.城市拉丁美洲糖尿病和空腹血糖受损的高患病率:CARMELA 研究。
Diabet Med. 2009 Sep;26(9):864-71. doi: 10.1111/j.1464-5491.2009.02795.x.

引用本文的文献

1
First cardiovascular event in patients with type 2 diabetes mellitus of a cardiovascular risk management program of a poor Colombian population: a cohort study.心血管风险管理制度下的贫困哥伦比亚人群 2 型糖尿病患者的首次心血管事件:一项队列研究。
BMC Cardiovasc Disord. 2019 Jan 8;19(1):8. doi: 10.1186/s12872-018-0993-z.
2
The cost of diabetes in Latin America and the Caribbean in 2015: Evidence for decision and policy makers.2015年拉丁美洲和加勒比地区糖尿病的成本:为决策者提供的证据
J Glob Health. 2017 Dec;7(2):020410. doi: 10.7189/jogh.07.020410.
3
Challenges associated with insulin therapy progression among patients with type 2 diabetes: Latin American MOSAIc study baseline data.
2型糖尿病患者胰岛素治疗进展相关挑战:拉丁美洲MOSAIc研究基线数据
Diabetol Metab Syndr. 2016 Jul 22;8:41. doi: 10.1186/s13098-016-0157-1. eCollection 2016.
4
Diabetes in Argentina: cost and management of diabetes and its complications and challenges for health policy.阿根廷的糖尿病:糖尿病及其并发症的成本和管理,以及对卫生政策的挑战。
Global Health. 2013 Oct 29;9:54. doi: 10.1186/1744-8603-9-54.